Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.31%
#2 aelf aelf +23.02%
#3 Venom Venom +19.12%
#4 Bitway Bitway +13.51%
#5 Pons Pons +10.65%
#6 Decred Decred +10.50%
#7 TRIA TRIA +9.00%
#8 MarsCoin MarsCoin +8.85%
#9 Wibx Wibx +8.12%
#10 AtomOne AtomOne +7.71%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
設定
言語
日本
通貨
USD
テーマ
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
株式のランク #30387
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
株価
$1.25
最終同期: 2026-08-18
時価総額
$17.05M
変化（1日）
-1.50%
変化（1年）
-22.24%
国
FR
取引 Aelis Farma S.A. (AELIS)

カテゴリー

Healthcare
Aelis Farma S.A.（AELIS）のP/B比率
2026 時点のP/B比率 TTM: 0
Aelis Farma S.A. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Aelis Farma S.A. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE